Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

HD+12, HD+15

K-Number: K220526 · 2023-05-15

Decision Date2023-05-15
Product CodeDRG
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

HD+12, HD+15 is a medical device manufactured by Cardioline S.P.A. It received FDA 510(k) clearance on 2023-05-15 under approval number K220526. The device is classified under product code DRG. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the HD+12, HD+15?

HD+12, HD+15 is a medical device that received FDA 510(k) clearance on 2023-05-15. It is manufactured by Cardioline S.P.A. The 510(k) number is K220526.

When was HD+12, HD+15 approved by the FDA?

HD+12, HD+15 received FDA 510(k) clearance on 2023-05-15, under approval number K220526.

What company makes HD+12, HD+15?

HD+12, HD+15 is manufactured by Cardioline S.P.A.

What is the FDA product code for HD+12, HD+15?

The FDA product code for HD+12, HD+15 is DRG.

Other Devices by Cardioline S.P.A

Related Devices (Code: DRG)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.